Presentation Theater #3: Biosimilars: Discussing Real World Considerations for Pharmacists


Biosimilars are projected to lower health care costs and deliver more therapeutic options for physicians and patients. This presentation provides an overview of key pharmacist-specific considerations for biosimilars, including details of the approval process, considerations for appropriate use, and practices that mitigate inadvertent substitution and encourage accurate adverse event reporting.

Speakers: Indu Lew, PharmD; Brad Jordan,PhD

Presented by Amgen Inc.

Interest: Presentation Theater
Session Time Slot(s): 
Saturday, March 23
1:30 PM - 2:30 PM
Washington State Convention Center - Hall EF